Skip to main content
. Author manuscript; available in PMC: 2019 Jul 29.
Published in final edited form as: J Leukoc Biol. 2018 Aug 26;104(6):1069–1085. doi: 10.1002/JLB.1RI0418-152RR

FIGURE 2. Transcriptional regulation of CD4+ T helper (TH) cells that mediate tissue inflammation.

FIGURE 2

CD4+ TH cells are a heterogeneous population of effector cells with a significant degree of genetic plasticity that enables them to acquire effector functions and the cytokine profiles of the opposing TH lineages. Generally, CD4+ TH plasticity is associated with more aggressive CD4+ TH responses and destructive inflammation-associated pathology. For example, TH17 cells trans-differentiate into TH1-like TH17 cells in an IL-23-dependent manner and drive tissue pathology in multiple sclerosis, inflammatory bowel disease, diabetes, and autoimmune arthritis. Similarly, uncommitted Treg cells, characterized by low Foxp3 and CD25 expression, can convert into IL-17A-producing effector cells and upregulate RANKL expression, which increases their osteoclastogenic activity. Such TH17-like Treg cells not only lost their suppressive functions, but also accelerated arthritis pathology. Future studies should be focused to elaborate and functionally characterize transcription factors that regulate the generation and functional plasticity of pathogenic CD4+ TH effector cells